TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI)
CUSIP: 89680M101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 61,418,480
- Total 13F shares
- 1,617,489
- Share change
- +691,782
- Total reported value
- $8,929,169
- Price per share
- $5.52
- Number of holders
- 26
- Value change
- +$3,605,411
- Number of buys
- 11
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 89680M101?
CUSIP 89680M101 identifies TLSI - TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89680M101:
Top shareholders of TLSI - TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MedTech Acquisition Sponsor LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
6,250,000
mixed-class rows
|
$65,538,115 | — | 26 Jun 2023 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.51%
|
315,955
|
$3,081,000 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.27%
|
167,159
|
$1,629,800 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
134,099
|
$1,307,942 | — | 31 Mar 2024 | |
| Magnetar Financial LLC |
13F
3/4/5
|
Company · 10%+ Owner |
—
class O/S missing
|
767,163
|
$843,879 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
54,475
|
$531,131 | — | 31 Mar 2024 | |
| James Alecxih |
3/4/5
|
President, Device Technology |
—
class O/S missing
|
94,754
|
$521,147 | — | 10 Aug 2023 | |
| Connecticut Wealth Management, LLC |
13F
|
Company |
0.07%
|
44,606
|
$434,909 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.07%
|
42,170
|
$411,158 | — | 31 Mar 2024 | |
| Steven C. Katz |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
173,587
mixed-class rows
|
$377,229 | — | 12 Feb 2024 | |
| Laird Norton Wetherby Wealth Management, LLC |
13F
|
Company |
0.06%
|
34,950
|
$340,763 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
—
mixed-class rows
|
333,334
mixed-class rows
|
$333,310 | — | 31 Mar 2024 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
—
class O/S missing
|
285,864
|
$285,835 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
28,423
|
$277,124 | — | 31 Mar 2024 | |
| Anson Capital, Inc. |
13F
|
Company |
0.04%
|
24,415
|
$238,046 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
17,696
|
$172,536 | — | 31 Mar 2024 | |
| Exos Asset Management LLC |
13F
|
Company |
—
class O/S missing
|
167,610
|
$167,593 | — | 31 Mar 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.03%
|
15,554
|
$152,000 | — | 31 Mar 2024 | |
| Vestcor Inc |
13F
|
Company |
—
class O/S missing
|
148,755
|
$149,000 | — | 31 Mar 2024 | |
| MSD Partners, L.P. |
13F
|
Company |
—
class O/S missing
|
133,333
|
$133,320 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
13,309
|
$129,763 | — | 31 Mar 2024 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
117,290
|
$117,278 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
10,559
|
$102,950 | — | 31 Mar 2024 | |
| Tyche Wealth Partners LLC |
13F
|
Company |
0.02%
|
10,000
|
$97,500 | — | 31 Mar 2024 | |
| Bracebridge Capital, LLC |
13F
|
Company |
—
class O/S missing
|
92,880
|
$92,871 | — | 31 Mar 2024 | |
| Walleye Capital LLC |
13F
|
Company |
—
class O/S missing
|
80,883
|
$80,875 | — | 31 Mar 2024 | |
| KIM, LLC |
13F
|
Company |
—
class O/S missing
|
79,007
|
$78,999 | — | 31 Mar 2024 | |
| Sequoia Financial Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
62,187
|
$62,181 | — | 31 Mar 2024 | |
| ARISTEIA CAPITAL, L.L.C. |
13F
|
Company |
—
class O/S missing
|
53,561
|
$58,917 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.01%
|
5,490
|
$53,528 | — | 31 Mar 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
—
class O/S missing
|
50,424
|
$50,418 | — | 31 Mar 2024 | |
| CastleKnight Management LP |
13F
|
Company |
—
class O/S missing
|
46,371
|
$46,371 | — | 31 Mar 2024 | |
| Walleye Trading LLC |
13F
|
Company |
—
class O/S missing
|
45,496
|
$45,491 | — | 31 Mar 2024 | |
| CLEAR STREET LLC |
13F
|
Company |
—
mixed-class rows
|
41,170
mixed-class rows
|
$41,175 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
—
class O/S missing
|
29,956
|
$29,000 | — | 31 Mar 2024 | |
| B & T Capital Management DBA Alpha Capital Management |
13F
|
Company |
—
class O/S missing
|
22,222
|
$22,220 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,168
|
$21,138 | — | 31 Mar 2024 | |
| Foster Victor Wealth Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
20,973
|
$20,973 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
mixed-class rows
|
1,584
mixed-class rows
|
$15,076 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,319
|
$12,861 | — | 31 Mar 2024 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
—
class O/S missing
|
10,800
|
$10,800 | — | 31 Mar 2024 | |
| Richard Charles Hoertkorn |
13F
|
Individual |
0%
|
668
|
$6,513 | — | 31 Mar 2024 | |
| GPS Wealth Strategies Group, LLC |
13F
|
Company |
0%
|
657
|
$6,406 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
391
|
$3,813 | — | 31 Mar 2024 | |
| SIGNATUREFD, LLC |
13F
|
Company |
0%
|
100
|
$975 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0%
|
291
|
$3 | — | 31 Mar 2024 |
Institutional Holders of TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI) as of Q2 2024
As of 30 Jun 2024,
TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,617,489 shares.
The largest 10 holders included
Duquesne Family Office LLC, VANGUARD GROUP INC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, Lido Advisors, LLC, WOLVERINE ASSET MANAGEMENT LLC, HRT FINANCIAL LP, Connecticut Wealth Management, LLC, and BlackRock Inc..
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
24
Q2 2024 holders
26
Holder diff
2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.